The global Liquid Biopsy Market, valued at US$3.65 billion in 2024 stood at US$4.03 billion in 2025 and is projected to ...

PanTracer LBx will strengthen NeoGenomics’ pan-solid tumor CGP portfolio and position it in the growing $3 to $5 billion ...

The oncology companion diagnostic market is projected to grow at a CAGR of ~10% over the forecast period. The market is driven by the growing adoption of precision medicine, rising cancer incidence, ...

Overview of Cell Isolation MarketThe global Cell Isolation Market is valued at USD 15.6 Billion in 2024 and is projected to reach a value of USD 60.56 Billion by 2035 at a CAGR (Compound Annual Growth ...

Analysts anticipate Exact Sciences to report an earnings per share (EPS) of $0.02. Anticipation surrounds Exact Sciences's ...

A groundbreaking multicenter clinical study published on July 30 in JAMA Surgery confirms the powerful diagnostic performance of the Destinex assay, a novel liquid biopsy that serves as the foundation ...

Telo Genomics Corp. (TSXV: TELO; OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and ...

Quadrants has released its latest Pharmacy Automation Startups/SMEs Companies Assessment, recognizing key players, including ...

Headwaters Capital sees deep value in Bio-Techne as academic cuts weigh on shares. Learn why this life sciences leader could ...

As technology rapidly evolves, the integration of cutting-edge innovations in medical devices is enabling clinicians to ...